China is forging ahead in the race to develop a vaccine to help control the COVID-19 pandemic, with Sinovac Biotech's experimental vaccine set to become the country's second and the world's third to enter final stage testing later this month.

Britain's GlaxoSmithKline (GSK) said on Tuesday it will develop and test a potential COVID-19 vaccine using its booster technology and Canadian biopharmaceutical firm Medicago's coronavirus-like particles.

If the packaging project is successful, the polymer-based coating could kill or disable the novel coronavirus if it comes into contact with your cereal box.

A leading scientist behind the University of Oxford's potential COVID-19 vaccine said on Wednesday the team has seen the right sort of immune response in trials but declined to give a firm timeframe for when it could be ready.

While some health officials say a coronavirus vaccine could be developed by the end of the year, others aren't so optimistic.

People on six continents already are getting jabs in the arm as the race for a COVID-19 vaccine enters a defining summer, with even bigger studies poised to prove if any shot really works -- and maybe offer a reality check.

Countries around the world are in a race to develop a coronavirus vaccine.

Scientists Byram Bridle and Shayan Sharif of the University of Guelph worry that some are offering too much hope that a vaccine can be created in a timely fashion.

Experts fear that without a detailed strategy, the allocation of vaccines could be extremely messy.

NB polio survivor encourages Canadians to get vaccinated against COVID-19 if and when a vaccine is developed.